Oteseconazole

Overview

Oteseconazole is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3311228).

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Oteseconazole expires 17 Mar 2036 and exclusivity 26 Apr 2032. Generic API sourcing typically opens up once these lapse.

Chemical identity

IUPAC name

(2R)-2-(2,4-difluorophenyl)-1,1-difluoro-3-(tetrazol-1-yl)-1-[5-[4-(2,2,2-trifluoroethoxy)phenyl]-2-pyridinyl]propan-2-ol

Canonical SMILES

C1=CC(=CC=C1C2=CN=C(C=C2)C([C@](CN3C=NN=N3)(C4=C(C=C(C=C4)F)F)O)(F)F)OCC(F)(F)F

InChIKey

IDUYJRXRDSPPRC-NRFANRHFSA-N